Xilong Scientific released its 2026 interim report, with total operating revenue of 4.307 billion yuan and net profit attributable to the parent company of 39.413 million yuan, ranking 22nd among peer companies that have already disclosed results. Net cash flow from operating activities was negative 199 million yuan, a decrease of 365 million yuan compared with the same period last year, down 220.58 percent year on year. The company's asset-liability ratio was 56.95 percent, gross margin was 7.30 percent, return on equity was 1.78 percent, and diluted earnings per share was 0.07 yuan. The number of shareholders was 92,000, and the top ten shareholders held 26.47 percent of the total share capital.
Xilong Chemical Co LtdNet profit of 39.413 million yuan with negative operating cash flow and declining margins indicate weak financial performance.
